Prostate cancer is one of the leading causes of cancer-related death in men. Most patients who are diagnosed during earlier stages usually respond...
Vous n'êtes pas connecté
Researchers have identified key factors that determine the success of leukemia cell therapies, including DLI, in achieving remission.
Prostate cancer is one of the leading causes of cancer-related death in men. Most patients who are diagnosed during earlier stages usually respond...
Prostate cancer is one of the leading causes of cancer-related death in men. Most patients who are diagnosed during earlier stages usually respond...
BEIJING, Sept. 16 (Xinhua) -- Chinese researchers have successfully created a multi-tissue single-cell expression atlas for dairy cattle, marking a...
DelveInsight’s, “BRAF-mutant Non-Small Cell Lung Cancer (BRAF + NSCLC) Pipeline Insight, 2025” report provides comprehensive...
DelveInsight’s, “BRAF-mutant Non-Small Cell Lung Cancer (BRAF + NSCLC) Pipeline Insight, 2025” report provides comprehensive...
A newly developed molecule brings together two powerful immunotherapy strategies in one treatment. Researchers at the University of Basel and...
Triple-negative breast cancer is particularly aggressive and difficult to treat, but recent research may offer a new way to target the often-deadly...
DelveInsight’s “B-Cell Non-Hodgkin Lymphoma Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and...
DelveInsight’s “B-Cell Non-Hodgkin Lymphoma Pipeline Insight 2025” report provides comprehensive insights about 75+ companies and...
In a preclinical study, researchers found that tamoxifen encourages uterine cell growth; the findings could change how some breast cancers are treated...